MMNFQ (MedMen Enterprises) ROE % Adjusted to Book Value: -493.21% (As of Mar. 2023)


What is MedMen Enterprises ROE % Adjusted to Book Value?

MedMen Enterprises MMNFQ -90.00% ROE % Adjusted to Book Value is -493.21% as of Mar. 2023.

MedMen Enterprises's ROE % for the quarter that ended in Mar. 2023 was -93.71%. MedMen Enterprises's PB Ratio for the quarter that ended in Mar. 2023 was 0.19. MedMen Enterprises's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 was -493.21%.

MedMen Enterprises ROE % Adjusted to Book Value Related Terms

MedMen Enterprises ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for MedMen Enterprises's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises ROE % Adjusted to Book Value Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -66.50 -21.01 -211.55 -84.06 -231.88

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.12 -416.10 33.31 -324.92 -493.21

MMNFQ vs ZTS, VTRS, NBIX: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMen Enterprises ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's ROE % Adjusted to Book Value falls into.


MedMen Enterprises ROE % Adjusted to Book Value Calculation

MedMen Enterprises's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-113.62% / 0.49
=-231.88%

MedMen Enterprises's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-93.71% / 0.19
=-493.21%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -493.21% mean?
MedMen Enterprises (MMNFQ) has a ROE % Adjusted to Book Value of -493.21% as of Mar. 2023. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MedMen Enterprises and its competitors.
Is MedMen Enterprises' ROE % Adjusted to Book Value too high?
MedMen Enterprises' current ROE % Adjusted to Book Value is -493.21%.
How does MedMen Enterprises' ROE % Adjusted to Book Value compare to ZTS and VTRS?
MedMen Enterprises' ROE % Adjusted to Book Value of -493.21% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MedMen Enterprises and its competitors. MedMen Enterprises's current ROE % Adjusted to Book Value is -493.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current ROE % Adjusted to Book Value of -493.21%. The current ROE % Adjusted to Book Value is -493.21%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current ROE % Adjusted to Book Value is -493.21% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMen Enterprises Business Description

Address 8740 S Sepulveda Boulevard, Suite 105, Los Angeles, CA, USA, 90045
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.